| Economics aspects of ageing population P Marešová, H Mohelská, K Kuča Procedia economics and finance 23, 534-538, 2015 | 114 | 2015 |
| The potential of medical device industry in technological and economical context P Maresova, M Penhaker, A Selamat, K Kuca Therapeutics and clinical risk management, 1505-1514, 2015 | 82 | 2015 |
| Medical device development process, and associated risks and legislative aspects-systematic review P Marešová, B Klimova, J Honegr, K Kuča, WNH Ibrahim, A Selamat Frontiers in public health 8, 308, 2020 | 47 | 2020 |
| Alzheimers disease: cost cuts call for novel drugs development and national strategy. P Marešová, B Klímová, K Kuča Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a …, 2015 | 41 | 2015 |
| Ethical Questions Linked to Rare Diseases and Orphan Drugs–A Systematic Review J Kacetl, P Marešová, R Maskuriy, A Selamat Risk management and healthcare policy, 2125-2148, 2020 | 35 | 2020 |
| Cost of treatment and care for people with Alzheimer’s disease: a meta-analysis P Marešová, J Dolejs, H Mohelska, LK Bryan Current Alzheimer Research 16 (14), 1245-1253, 2019 | 33 | 2019 |
| Knowledge management in Czech enterprises P Maresova E & M EKONOMIE A MANAGEMENT 13 (1), 131-144, 2010 | 28 | 2010 |
| Deployment of cloud computing in small and medium size enterprises in the Czech republic P Marešová, V Hálek Technická univerzita v Liberci, 2014 | 27 | 2014 |
| Výzkum uplatnění znalostního managementu v českých podnicích P Marešová Technická univerzita v Liberci, 2010 | 25 | 2010 |
| The economic burden of the care and treatment for people with Alzheimer’s disease: the outlook for the Czech Republic P Marešová, V Zahálková Neurological Sciences 37, 1917-1922, 2016 | 24 | 2016 |
| Měření ve znalostním managementu-aplikace metody Cost Benefit Analysis P Marešová Gaudeamus, 2012 | 24 | 2012 |
| A comprehensive view on evaluation of cluster initiatives V Bureš, V Jašíková, T Otčenášková, K Kolerová, V Zubr, P Marešová 8th European Conference on Management Leadership and Governance ECMLG-12, 74-79, 2012 | 20 | 2012 |
| Cooperation policy of rare diseases in the European Union P Marešová, H Mohelská, K Kuča Procedia-Social and Behavioral Sciences 171, 1302-1308, 2015 | 19 | 2015 |
| Onset of mortality increase with age and age trajectories of mortality from all diseases in the four Nordic countries J Dolejs, P Marešová Clinical Interventions in Aging, 161-173, 2017 | 18 | 2017 |
| Critical factors and economic methods for regulatory impact assessment in the medical device industry J Maci, P Marešová Risk Management and Healthcare Policy, 71-91, 2022 | 17 | 2022 |
| Call for a uniform strategy of collecting Alzheimer’s disease costs: a review and meta-analysis P Marešová, J Dolejš, K Kuca Journal of Alzheimer's Disease 63 (1), 227-238, 2018 | 17 | 2018 |
| University of Hradec Kralove: Hradec Kralove P Jedlicka, P Marešová, I Soukal Czech Republic 8, 196-205, 2018 | 15 | 2018 |
| Complexity stage model of the medical device development based on economic evaluation—MedDee P Marešová, L Peter, J Honegr, L Režný, M Penhaker, M Augustýnek, ... Sustainability 12 (5), 1755, 2020 | 14 | 2020 |
| Use effectiveness of medical devices: a case study on the deployment of ultrasonographic devices M Augustýnek, D Laryš, J Kubíček, P Marešová, K Kuča Therapeutic innovation & regulatory science 52 (4), 499-506, 2018 | 14 | 2018 |
| Effective evaluation of cloud computing investment: application of cost benefit method analysis P Marešová, V Soběslav Technická univerzita v Liberci, 2017 | 11 | 2017 |